nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A5—Niacin—coronary artery disease	0.107	0.19	CbGbCtD
Ipratropium bromide—SLC22A5—Furosemide—coronary artery disease	0.0705	0.125	CbGbCtD
Ipratropium bromide—CYP3A4—Ticagrelor—coronary artery disease	0.0348	0.0617	CbGbCtD
Ipratropium bromide—CYP3A4—Fenofibrate—coronary artery disease	0.031	0.055	CbGbCtD
Ipratropium bromide—CYP2D6—Niacin—coronary artery disease	0.0256	0.0455	CbGbCtD
Ipratropium bromide—CYP3A4—Gemfibrozil—coronary artery disease	0.0248	0.044	CbGbCtD
Ipratropium bromide—CYP2D6—Timolol—coronary artery disease	0.0238	0.0423	CbGbCtD
Ipratropium bromide—CYP3A4—Clopidogrel—coronary artery disease	0.0215	0.0381	CbGbCtD
Ipratropium bromide—CYP2D6—Captopril—coronary artery disease	0.021	0.0372	CbGbCtD
Ipratropium bromide—CYP2D6—Simvastatin—coronary artery disease	0.0203	0.0359	CbGbCtD
Ipratropium bromide—CYP3A4—Eplerenone—coronary artery disease	0.02	0.0355	CbGbCtD
Ipratropium bromide—CYP2D6—Pravastatin—coronary artery disease	0.0198	0.0352	CbGbCtD
Ipratropium bromide—CYP2D6—Lovastatin—coronary artery disease	0.0198	0.0352	CbGbCtD
Ipratropium bromide—CYP2D6—Atorvastatin—coronary artery disease	0.0181	0.032	CbGbCtD
Ipratropium bromide—CYP3A4—Enalapril—coronary artery disease	0.0178	0.0316	CbGbCtD
Ipratropium bromide—CYP3A4—Rosuvastatin—coronary artery disease	0.0139	0.0246	CbGbCtD
Ipratropium bromide—CYP3A4—Ezetimibe—coronary artery disease	0.0139	0.0246	CbGbCtD
Ipratropium bromide—CYP3A4—Simvastatin—coronary artery disease	0.0129	0.0228	CbGbCtD
Ipratropium bromide—CYP3A4—Pravastatin—coronary artery disease	0.0126	0.0224	CbGbCtD
Ipratropium bromide—CYP3A4—Lovastatin—coronary artery disease	0.0126	0.0224	CbGbCtD
Ipratropium bromide—CYP3A4—Atorvastatin—coronary artery disease	0.0115	0.0204	CbGbCtD
Ipratropium bromide—CYP3A4—Losartan—coronary artery disease	0.0105	0.0186	CbGbCtD
Ipratropium bromide—Dizziness—Eplerenone—coronary artery disease	0.000129	0.000433	CcSEcCtD
Ipratropium bromide—Rash—Clopidogrel—coronary artery disease	0.000129	0.000433	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000129	0.000433	CcSEcCtD
Ipratropium bromide—Dermatitis—Clopidogrel—coronary artery disease	0.000129	0.000433	CcSEcCtD
Ipratropium bromide—Asthenia—Valsartan—coronary artery disease	0.000129	0.000432	CcSEcCtD
Ipratropium bromide—Hypertension—Timolol—coronary artery disease	0.000129	0.000432	CcSEcCtD
Ipratropium bromide—Constipation—Furosemide—coronary artery disease	0.000129	0.000432	CcSEcCtD
Ipratropium bromide—Pain—Furosemide—coronary artery disease	0.000129	0.000432	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Niacin—coronary artery disease	0.000129	0.000432	CcSEcCtD
Ipratropium bromide—Asthenia—Olmesartan—coronary artery disease	0.000128	0.00043	CcSEcCtD
Ipratropium bromide—Headache—Clopidogrel—coronary artery disease	0.000128	0.00043	CcSEcCtD
Ipratropium bromide—Rash—Lovastatin—coronary artery disease	0.000128	0.00043	CcSEcCtD
Ipratropium bromide—Dermatitis—Lovastatin—coronary artery disease	0.000128	0.00043	CcSEcCtD
Ipratropium bromide—Dyspepsia—Losartan—coronary artery disease	0.000128	0.000429	CcSEcCtD
Ipratropium bromide—Headache—Lovastatin—coronary artery disease	0.000127	0.000427	CcSEcCtD
Ipratropium bromide—Pruritus—Valsartan—coronary artery disease	0.000127	0.000426	CcSEcCtD
Ipratropium bromide—Dry mouth—Ramipril—coronary artery disease	0.000127	0.000426	CcSEcCtD
Ipratropium bromide—Myalgia—Timolol—coronary artery disease	0.000127	0.000426	CcSEcCtD
Ipratropium bromide—Chest pain—Timolol—coronary artery disease	0.000127	0.000426	CcSEcCtD
Ipratropium bromide—Vomiting—Ezetimibe—coronary artery disease	0.000127	0.000425	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Pravastatin—coronary artery disease	0.000127	0.000425	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Perindopril—coronary artery disease	0.000127	0.000425	CcSEcCtD
Ipratropium bromide—Angioedema—Lisinopril—coronary artery disease	0.000127	0.000424	CcSEcCtD
Ipratropium bromide—Pruritus—Olmesartan—coronary artery disease	0.000126	0.000424	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000126	0.000423	CcSEcCtD
Ipratropium bromide—Abdominal pain—Captopril—coronary artery disease	0.000126	0.000423	CcSEcCtD
Ipratropium bromide—Dizziness—Simvastatin—coronary artery disease	0.000126	0.000422	CcSEcCtD
Ipratropium bromide—Rash—Ezetimibe—coronary artery disease	0.000126	0.000422	CcSEcCtD
Ipratropium bromide—Dermatitis—Ezetimibe—coronary artery disease	0.000126	0.000421	CcSEcCtD
Ipratropium bromide—Asthenia—Niacin—coronary artery disease	0.000125	0.00042	CcSEcCtD
Ipratropium bromide—Fatigue—Losartan—coronary artery disease	0.000125	0.00042	CcSEcCtD
Ipratropium bromide—Headache—Ezetimibe—coronary artery disease	0.000125	0.000419	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Ramipril—coronary artery disease	0.000125	0.000418	CcSEcCtD
Ipratropium bromide—Oedema—Ramipril—coronary artery disease	0.000125	0.000418	CcSEcCtD
Ipratropium bromide—Dry mouth—Timolol—coronary artery disease	0.000124	0.000417	CcSEcCtD
Ipratropium bromide—Constipation—Losartan—coronary artery disease	0.000124	0.000417	CcSEcCtD
Ipratropium bromide—Pain—Losartan—coronary artery disease	0.000124	0.000417	CcSEcCtD
Ipratropium bromide—Vomiting—Eplerenone—coronary artery disease	0.000124	0.000416	CcSEcCtD
Ipratropium bromide—Nausea—Fenofibrate—coronary artery disease	0.000124	0.000415	CcSEcCtD
Ipratropium bromide—Pruritus—Niacin—coronary artery disease	0.000124	0.000414	CcSEcCtD
Ipratropium bromide—Asthenia—Pravastatin—coronary artery disease	0.000123	0.000414	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Furosemide—coronary artery disease	0.000123	0.000413	CcSEcCtD
Ipratropium bromide—Rash—Eplerenone—coronary artery disease	0.000123	0.000413	CcSEcCtD
Ipratropium bromide—Urticaria—Perindopril—coronary artery disease	0.000123	0.000413	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Trandolapril—coronary artery disease	0.000123	0.000413	CcSEcCtD
Ipratropium bromide—Dermatitis—Eplerenone—coronary artery disease	0.000123	0.000413	CcSEcCtD
Ipratropium bromide—Diarrhoea—Valsartan—coronary artery disease	0.000123	0.000412	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Enalapril—coronary artery disease	0.000123	0.000411	CcSEcCtD
Ipratropium bromide—Abdominal pain—Perindopril—coronary artery disease	0.000122	0.000411	CcSEcCtD
Ipratropium bromide—Palpitations—Lisinopril—coronary artery disease	0.000122	0.00041	CcSEcCtD
Ipratropium bromide—Diarrhoea—Olmesartan—coronary artery disease	0.000122	0.00041	CcSEcCtD
Ipratropium bromide—Headache—Eplerenone—coronary artery disease	0.000122	0.00041	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Ramipril—coronary artery disease	0.000122	0.00041	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Timolol—coronary artery disease	0.000122	0.000408	CcSEcCtD
Ipratropium bromide—Oedema—Timolol—coronary artery disease	0.000122	0.000408	CcSEcCtD
Ipratropium bromide—Pruritus—Pravastatin—coronary artery disease	0.000122	0.000408	CcSEcCtD
Ipratropium bromide—Nausea—Clopidogrel—coronary artery disease	0.000122	0.000408	CcSEcCtD
Ipratropium bromide—Tachycardia—Ramipril—coronary artery disease	0.000122	0.000408	CcSEcCtD
Ipratropium bromide—Skin disorder—Ramipril—coronary artery disease	0.000121	0.000406	CcSEcCtD
Ipratropium bromide—Infection—Timolol—coronary artery disease	0.000121	0.000406	CcSEcCtD
Ipratropium bromide—Vomiting—Simvastatin—coronary artery disease	0.000121	0.000406	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Telmisartan—coronary artery disease	0.000121	0.000405	CcSEcCtD
Ipratropium bromide—Cough—Lisinopril—coronary artery disease	0.000121	0.000405	CcSEcCtD
Ipratropium bromide—Nausea—Lovastatin—coronary artery disease	0.000121	0.000405	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Ramipril—coronary artery disease	0.00012	0.000404	CcSEcCtD
Ipratropium bromide—Rash—Simvastatin—coronary artery disease	0.00012	0.000402	CcSEcCtD
Ipratropium bromide—Dermatitis—Simvastatin—coronary artery disease	0.00012	0.000402	CcSEcCtD
Ipratropium bromide—Asthenia—Trandolapril—coronary artery disease	0.00012	0.000402	CcSEcCtD
Ipratropium bromide—Urticaria—Furosemide—coronary artery disease	0.00012	0.000401	CcSEcCtD
Ipratropium bromide—Diarrhoea—Niacin—coronary artery disease	0.00012	0.000401	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Timolol—coronary artery disease	0.000119	0.000401	CcSEcCtD
Ipratropium bromide—Asthenia—Enalapril—coronary artery disease	0.000119	0.0004	CcSEcCtD
Ipratropium bromide—Headache—Simvastatin—coronary artery disease	0.000119	0.0004	CcSEcCtD
Ipratropium bromide—Abdominal pain—Furosemide—coronary artery disease	0.000119	0.000399	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Losartan—coronary artery disease	0.000119	0.000398	CcSEcCtD
Ipratropium bromide—Dizziness—Valsartan—coronary artery disease	0.000119	0.000398	CcSEcCtD
Ipratropium bromide—Nausea—Ezetimibe—coronary artery disease	0.000118	0.000397	CcSEcCtD
Ipratropium bromide—Skin disorder—Timolol—coronary artery disease	0.000118	0.000397	CcSEcCtD
Ipratropium bromide—Dizziness—Olmesartan—coronary artery disease	0.000118	0.000397	CcSEcCtD
Ipratropium bromide—Pruritus—Trandolapril—coronary artery disease	0.000118	0.000396	CcSEcCtD
Ipratropium bromide—Myalgia—Lisinopril—coronary artery disease	0.000118	0.000395	CcSEcCtD
Ipratropium bromide—Chest pain—Lisinopril—coronary artery disease	0.000118	0.000395	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Timolol—coronary artery disease	0.000118	0.000395	CcSEcCtD
Ipratropium bromide—Asthenia—Telmisartan—coronary artery disease	0.000118	0.000395	CcSEcCtD
Ipratropium bromide—Pruritus—Enalapril—coronary artery disease	0.000118	0.000395	CcSEcCtD
Ipratropium bromide—Diarrhoea—Pravastatin—coronary artery disease	0.000118	0.000395	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000117	0.000393	CcSEcCtD
Ipratropium bromide—Hypotension—Ramipril—coronary artery disease	0.000116	0.00039	CcSEcCtD
Ipratropium bromide—Pruritus—Telmisartan—coronary artery disease	0.000116	0.000389	CcSEcCtD
Ipratropium bromide—Nausea—Eplerenone—coronary artery disease	0.000116	0.000389	CcSEcCtD
Ipratropium bromide—Dizziness—Niacin—coronary artery disease	0.000116	0.000387	CcSEcCtD
Ipratropium bromide—Urticaria—Losartan—coronary artery disease	0.000115	0.000387	CcSEcCtD
Ipratropium bromide—Dry mouth—Lisinopril—coronary artery disease	0.000115	0.000387	CcSEcCtD
Ipratropium bromide—Abdominal pain—Losartan—coronary artery disease	0.000115	0.000385	CcSEcCtD
Ipratropium bromide—Asthenia—Captopril—coronary artery disease	0.000114	0.000384	CcSEcCtD
Ipratropium bromide—Diarrhoea—Trandolapril—coronary artery disease	0.000114	0.000383	CcSEcCtD
Ipratropium bromide—Vomiting—Valsartan—coronary artery disease	0.000114	0.000383	CcSEcCtD
Ipratropium bromide—Diarrhoea—Enalapril—coronary artery disease	0.000114	0.000382	CcSEcCtD
Ipratropium bromide—Hypotension—Timolol—coronary artery disease	0.000114	0.000382	CcSEcCtD
Ipratropium bromide—Dizziness—Pravastatin—coronary artery disease	0.000114	0.000381	CcSEcCtD
Ipratropium bromide—Vomiting—Olmesartan—coronary artery disease	0.000114	0.000381	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000114	0.000381	CcSEcCtD
Ipratropium bromide—Rash—Valsartan—coronary artery disease	0.000113	0.00038	CcSEcCtD
Ipratropium bromide—Dermatitis—Valsartan—coronary artery disease	0.000113	0.00038	CcSEcCtD
Ipratropium bromide—Nausea—Simvastatin—coronary artery disease	0.000113	0.000379	CcSEcCtD
Ipratropium bromide—Oedema—Lisinopril—coronary artery disease	0.000113	0.000379	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Lisinopril—coronary artery disease	0.000113	0.000379	CcSEcCtD
Ipratropium bromide—Pruritus—Captopril—coronary artery disease	0.000113	0.000379	CcSEcCtD
Ipratropium bromide—Rash—Olmesartan—coronary artery disease	0.000113	0.000378	CcSEcCtD
Ipratropium bromide—Insomnia—Ramipril—coronary artery disease	0.000113	0.000378	CcSEcCtD
Ipratropium bromide—Dermatitis—Olmesartan—coronary artery disease	0.000113	0.000378	CcSEcCtD
Ipratropium bromide—Headache—Valsartan—coronary artery disease	0.000113	0.000377	CcSEcCtD
Ipratropium bromide—Diarrhoea—Telmisartan—coronary artery disease	0.000112	0.000377	CcSEcCtD
Ipratropium bromide—Infection—Lisinopril—coronary artery disease	0.000112	0.000376	CcSEcCtD
Ipratropium bromide—Headache—Olmesartan—coronary artery disease	0.000112	0.000376	CcSEcCtD
Ipratropium bromide—Paraesthesia—Ramipril—coronary artery disease	0.000112	0.000375	CcSEcCtD
Ipratropium bromide—Asthenia—Perindopril—coronary artery disease	0.000111	0.000373	CcSEcCtD
Ipratropium bromide—Dyspnoea—Ramipril—coronary artery disease	0.000111	0.000373	CcSEcCtD
Ipratropium bromide—Vomiting—Niacin—coronary artery disease	0.000111	0.000372	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000111	0.000372	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Furosemide—coronary artery disease	0.000111	0.000372	CcSEcCtD
Ipratropium bromide—Somnolence—Ramipril—coronary artery disease	0.000111	0.000371	CcSEcCtD
Ipratropium bromide—Dizziness—Trandolapril—coronary artery disease	0.00011	0.00037	CcSEcCtD
Ipratropium bromide—Tachycardia—Lisinopril—coronary artery disease	0.00011	0.00037	CcSEcCtD
Ipratropium bromide—Insomnia—Timolol—coronary artery disease	0.00011	0.000369	CcSEcCtD
Ipratropium bromide—Rash—Niacin—coronary artery disease	0.00011	0.000369	CcSEcCtD
Ipratropium bromide—Dermatitis—Niacin—coronary artery disease	0.00011	0.000369	CcSEcCtD
Ipratropium bromide—Dizziness—Enalapril—coronary artery disease	0.00011	0.000369	CcSEcCtD
Ipratropium bromide—Skin disorder—Lisinopril—coronary artery disease	0.00011	0.000368	CcSEcCtD
Ipratropium bromide—Dyspepsia—Ramipril—coronary artery disease	0.00011	0.000368	CcSEcCtD
Ipratropium bromide—Pruritus—Perindopril—coronary artery disease	0.00011	0.000368	CcSEcCtD
Ipratropium bromide—Headache—Niacin—coronary artery disease	0.000109	0.000367	CcSEcCtD
Ipratropium bromide—Paraesthesia—Timolol—coronary artery disease	0.000109	0.000367	CcSEcCtD
Ipratropium bromide—Vomiting—Pravastatin—coronary artery disease	0.000109	0.000367	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Lisinopril—coronary artery disease	0.000109	0.000366	CcSEcCtD
Ipratropium bromide—Diarrhoea—Captopril—coronary artery disease	0.000109	0.000366	CcSEcCtD
Ipratropium bromide—Dyspnoea—Timolol—coronary artery disease	0.000109	0.000364	CcSEcCtD
Ipratropium bromide—Dizziness—Telmisartan—coronary artery disease	0.000109	0.000364	CcSEcCtD
Ipratropium bromide—Rash—Pravastatin—coronary artery disease	0.000108	0.000364	CcSEcCtD
Ipratropium bromide—Dermatitis—Pravastatin—coronary artery disease	0.000108	0.000363	CcSEcCtD
Ipratropium bromide—Somnolence—Timolol—coronary artery disease	0.000108	0.000363	CcSEcCtD
Ipratropium bromide—Asthenia—Furosemide—coronary artery disease	0.000108	0.000362	CcSEcCtD
Ipratropium bromide—Headache—Pravastatin—coronary artery disease	0.000108	0.000361	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000108	0.000361	CcSEcCtD
Ipratropium bromide—Fatigue—Ramipril—coronary artery disease	0.000107	0.00036	CcSEcCtD
Ipratropium bromide—Dyspepsia—Timolol—coronary artery disease	0.000107	0.00036	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Losartan—coronary artery disease	0.000107	0.000359	CcSEcCtD
Ipratropium bromide—Nausea—Valsartan—coronary artery disease	0.000107	0.000358	CcSEcCtD
Ipratropium bromide—Pruritus—Furosemide—coronary artery disease	0.000107	0.000357	CcSEcCtD
Ipratropium bromide—Constipation—Ramipril—coronary artery disease	0.000107	0.000357	CcSEcCtD
Ipratropium bromide—Nausea—Olmesartan—coronary artery disease	0.000106	0.000356	CcSEcCtD
Ipratropium bromide—Vomiting—Trandolapril—coronary artery disease	0.000106	0.000356	CcSEcCtD
Ipratropium bromide—Diarrhoea—Perindopril—coronary artery disease	0.000106	0.000355	CcSEcCtD
Ipratropium bromide—Vomiting—Enalapril—coronary artery disease	0.000106	0.000355	CcSEcCtD
Ipratropium bromide—Hypotension—Lisinopril—coronary artery disease	0.000106	0.000354	CcSEcCtD
Ipratropium bromide—Dizziness—Captopril—coronary artery disease	0.000106	0.000354	CcSEcCtD
Ipratropium bromide—Rash—Trandolapril—coronary artery disease	0.000105	0.000353	CcSEcCtD
Ipratropium bromide—Dermatitis—Trandolapril—coronary artery disease	0.000105	0.000353	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Timolol—coronary artery disease	0.000105	0.000353	CcSEcCtD
Ipratropium bromide—Fatigue—Timolol—coronary artery disease	0.000105	0.000352	CcSEcCtD
Ipratropium bromide—Rash—Enalapril—coronary artery disease	0.000105	0.000352	CcSEcCtD
Ipratropium bromide—Dermatitis—Enalapril—coronary artery disease	0.000105	0.000351	CcSEcCtD
Ipratropium bromide—Headache—Trandolapril—coronary artery disease	0.000105	0.000351	CcSEcCtD
Ipratropium bromide—Vomiting—Telmisartan—coronary artery disease	0.000104	0.00035	CcSEcCtD
Ipratropium bromide—Asthenia—Losartan—coronary artery disease	0.000104	0.00035	CcSEcCtD
Ipratropium bromide—Headache—Enalapril—coronary artery disease	0.000104	0.00035	CcSEcCtD
Ipratropium bromide—Pain—Timolol—coronary artery disease	0.000104	0.000349	CcSEcCtD
Ipratropium bromide—Nausea—Niacin—coronary artery disease	0.000104	0.000348	CcSEcCtD
Ipratropium bromide—Rash—Telmisartan—coronary artery disease	0.000103	0.000347	CcSEcCtD
Ipratropium bromide—Dermatitis—Telmisartan—coronary artery disease	0.000103	0.000347	CcSEcCtD
Ipratropium bromide—Diarrhoea—Furosemide—coronary artery disease	0.000103	0.000346	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000103	0.000345	CcSEcCtD
Ipratropium bromide—Pruritus—Losartan—coronary artery disease	0.000103	0.000345	CcSEcCtD
Ipratropium bromide—Headache—Telmisartan—coronary artery disease	0.000103	0.000345	CcSEcCtD
Ipratropium bromide—Dizziness—Perindopril—coronary artery disease	0.000102	0.000344	CcSEcCtD
Ipratropium bromide—Insomnia—Lisinopril—coronary artery disease	0.000102	0.000343	CcSEcCtD
Ipratropium bromide—Nausea—Pravastatin—coronary artery disease	0.000102	0.000343	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Ramipril—coronary artery disease	0.000102	0.000342	CcSEcCtD
Ipratropium bromide—Paraesthesia—Lisinopril—coronary artery disease	0.000101	0.00034	CcSEcCtD
Ipratropium bromide—Vomiting—Captopril—coronary artery disease	0.000101	0.00034	CcSEcCtD
Ipratropium bromide—Dyspnoea—Lisinopril—coronary artery disease	0.000101	0.000338	CcSEcCtD
Ipratropium bromide—Rash—Captopril—coronary artery disease	0.000101	0.000337	CcSEcCtD
Ipratropium bromide—Dermatitis—Captopril—coronary artery disease	0.000101	0.000337	CcSEcCtD
Ipratropium bromide—Somnolence—Lisinopril—coronary artery disease	0.0001	0.000337	CcSEcCtD
Ipratropium bromide—Headache—Captopril—coronary artery disease	0.0001	0.000335	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Timolol—coronary artery disease	9.96e-05	0.000334	CcSEcCtD
Ipratropium bromide—Dizziness—Furosemide—coronary artery disease	9.96e-05	0.000334	CcSEcCtD
Ipratropium bromide—Dyspepsia—Lisinopril—coronary artery disease	9.95e-05	0.000334	CcSEcCtD
Ipratropium bromide—Diarrhoea—Losartan—coronary artery disease	9.94e-05	0.000333	CcSEcCtD
Ipratropium bromide—Nausea—Trandolapril—coronary artery disease	9.92e-05	0.000333	CcSEcCtD
Ipratropium bromide—Urticaria—Ramipril—coronary artery disease	9.9e-05	0.000332	CcSEcCtD
Ipratropium bromide—Nausea—Enalapril—coronary artery disease	9.88e-05	0.000331	CcSEcCtD
Ipratropium bromide—Vomiting—Perindopril—coronary artery disease	9.85e-05	0.00033	CcSEcCtD
Ipratropium bromide—Abdominal pain—Ramipril—coronary artery disease	9.85e-05	0.00033	CcSEcCtD
Ipratropium bromide—Rash—Perindopril—coronary artery disease	9.77e-05	0.000328	CcSEcCtD
Ipratropium bromide—Dermatitis—Perindopril—coronary artery disease	9.76e-05	0.000327	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Lisinopril—coronary artery disease	9.75e-05	0.000327	CcSEcCtD
Ipratropium bromide—Nausea—Telmisartan—coronary artery disease	9.75e-05	0.000327	CcSEcCtD
Ipratropium bromide—Fatigue—Lisinopril—coronary artery disease	9.74e-05	0.000327	CcSEcCtD
Ipratropium bromide—Headache—Perindopril—coronary artery disease	9.7e-05	0.000325	CcSEcCtD
Ipratropium bromide—Urticaria—Timolol—coronary artery disease	9.68e-05	0.000325	CcSEcCtD
Ipratropium bromide—Constipation—Lisinopril—coronary artery disease	9.66e-05	0.000324	CcSEcCtD
Ipratropium bromide—Pain—Lisinopril—coronary artery disease	9.66e-05	0.000324	CcSEcCtD
Ipratropium bromide—Abdominal pain—Timolol—coronary artery disease	9.63e-05	0.000323	CcSEcCtD
Ipratropium bromide—Dizziness—Losartan—coronary artery disease	9.61e-05	0.000322	CcSEcCtD
Ipratropium bromide—Vomiting—Furosemide—coronary artery disease	9.57e-05	0.000321	CcSEcCtD
Ipratropium bromide—Rash—Furosemide—coronary artery disease	9.5e-05	0.000318	CcSEcCtD
Ipratropium bromide—Dermatitis—Furosemide—coronary artery disease	9.49e-05	0.000318	CcSEcCtD
Ipratropium bromide—Nausea—Captopril—coronary artery disease	9.48e-05	0.000318	CcSEcCtD
Ipratropium bromide—Headache—Furosemide—coronary artery disease	9.43e-05	0.000316	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Lisinopril—coronary artery disease	9.24e-05	0.00031	CcSEcCtD
Ipratropium bromide—Vomiting—Losartan—coronary artery disease	9.24e-05	0.00031	CcSEcCtD
Ipratropium bromide—Nausea—Perindopril—coronary artery disease	9.2e-05	0.000309	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Ramipril—coronary artery disease	9.18e-05	0.000308	CcSEcCtD
Ipratropium bromide—Rash—Losartan—coronary artery disease	9.16e-05	0.000307	CcSEcCtD
Ipratropium bromide—Dermatitis—Losartan—coronary artery disease	9.15e-05	0.000307	CcSEcCtD
Ipratropium bromide—Headache—Losartan—coronary artery disease	9.1e-05	0.000305	CcSEcCtD
Ipratropium bromide—Urticaria—Lisinopril—coronary artery disease	8.98e-05	0.000301	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Timolol—coronary artery disease	8.97e-05	0.000301	CcSEcCtD
Ipratropium bromide—Nausea—Furosemide—coronary artery disease	8.94e-05	0.0003	CcSEcCtD
Ipratropium bromide—Asthenia—Ramipril—coronary artery disease	8.94e-05	0.0003	CcSEcCtD
Ipratropium bromide—Abdominal pain—Lisinopril—coronary artery disease	8.93e-05	0.0003	CcSEcCtD
Ipratropium bromide—Pruritus—Ramipril—coronary artery disease	8.81e-05	0.000296	CcSEcCtD
Ipratropium bromide—Asthenia—Timolol—coronary artery disease	8.74e-05	0.000293	CcSEcCtD
Ipratropium bromide—Nausea—Losartan—coronary artery disease	8.63e-05	0.000289	CcSEcCtD
Ipratropium bromide—Pruritus—Timolol—coronary artery disease	8.62e-05	0.000289	CcSEcCtD
Ipratropium bromide—Diarrhoea—Ramipril—coronary artery disease	8.52e-05	0.000286	CcSEcCtD
Ipratropium bromide—Diarrhoea—Timolol—coronary artery disease	8.33e-05	0.000279	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Lisinopril—coronary artery disease	8.32e-05	0.000279	CcSEcCtD
Ipratropium bromide—Dizziness—Ramipril—coronary artery disease	8.24e-05	0.000276	CcSEcCtD
Ipratropium bromide—Asthenia—Lisinopril—coronary artery disease	8.11e-05	0.000272	CcSEcCtD
Ipratropium bromide—Dizziness—Timolol—coronary artery disease	8.05e-05	0.00027	CcSEcCtD
Ipratropium bromide—Pruritus—Lisinopril—coronary artery disease	7.99e-05	0.000268	CcSEcCtD
Ipratropium bromide—Vomiting—Ramipril—coronary artery disease	7.92e-05	0.000266	CcSEcCtD
Ipratropium bromide—Rash—Ramipril—coronary artery disease	7.86e-05	0.000263	CcSEcCtD
Ipratropium bromide—Dermatitis—Ramipril—coronary artery disease	7.85e-05	0.000263	CcSEcCtD
Ipratropium bromide—Headache—Ramipril—coronary artery disease	7.81e-05	0.000262	CcSEcCtD
Ipratropium bromide—Vomiting—Timolol—coronary artery disease	7.74e-05	0.00026	CcSEcCtD
Ipratropium bromide—Diarrhoea—Lisinopril—coronary artery disease	7.73e-05	0.000259	CcSEcCtD
Ipratropium bromide—Rash—Timolol—coronary artery disease	7.68e-05	0.000258	CcSEcCtD
Ipratropium bromide—Dermatitis—Timolol—coronary artery disease	7.67e-05	0.000257	CcSEcCtD
Ipratropium bromide—Headache—Timolol—coronary artery disease	7.63e-05	0.000256	CcSEcCtD
Ipratropium bromide—Dizziness—Lisinopril—coronary artery disease	7.47e-05	0.000251	CcSEcCtD
Ipratropium bromide—Nausea—Ramipril—coronary artery disease	7.4e-05	0.000248	CcSEcCtD
Ipratropium bromide—Nausea—Timolol—coronary artery disease	7.23e-05	0.000243	CcSEcCtD
Ipratropium bromide—Vomiting—Lisinopril—coronary artery disease	7.18e-05	0.000241	CcSEcCtD
Ipratropium bromide—Rash—Lisinopril—coronary artery disease	7.12e-05	0.000239	CcSEcCtD
Ipratropium bromide—Dermatitis—Lisinopril—coronary artery disease	7.12e-05	0.000239	CcSEcCtD
Ipratropium bromide—Headache—Lisinopril—coronary artery disease	7.08e-05	0.000237	CcSEcCtD
Ipratropium bromide—Nausea—Lisinopril—coronary artery disease	6.71e-05	0.000225	CcSEcCtD
Ipratropium bromide—CHRM2—Signaling Pathways—CSF2—coronary artery disease	7.55e-06	5.48e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGF1—coronary artery disease	7.55e-06	5.48e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	7.52e-06	5.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	7.52e-06	5.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	7.5e-06	5.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	7.5e-06	5.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—APOA1—coronary artery disease	7.5e-06	5.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LPL—coronary artery disease	7.49e-06	5.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IGF1—coronary artery disease	7.47e-06	5.42e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HADHA—coronary artery disease	7.47e-06	5.42e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—MAPK1—coronary artery disease	7.43e-06	5.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	7.43e-06	5.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	7.43e-06	5.39e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTA1—coronary artery disease	7.38e-06	5.36e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	7.33e-06	5.32e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	7.31e-06	5.3e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LPA—coronary artery disease	7.3e-06	5.3e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	7.24e-06	5.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	7.16e-06	5.19e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	7.14e-06	5.18e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	7.12e-06	5.17e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PLCB1—coronary artery disease	7.11e-06	5.16e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—PIK3CA—coronary artery disease	7.1e-06	5.15e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	7.1e-06	5.15e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SERPINE1—coronary artery disease	7.09e-06	5.15e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PLCB3—coronary artery disease	7.07e-06	5.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	7.07e-06	5.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	7.03e-06	5.1e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOA5—coronary artery disease	7e-06	5.08e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	6.99e-06	5.08e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	6.97e-06	5.06e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	6.9e-06	5.01e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ABCA1—coronary artery disease	6.9e-06	5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FGF2—coronary artery disease	6.86e-06	4.98e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—P4HB—coronary artery disease	6.86e-06	4.98e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	6.84e-06	4.97e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—C3—coronary artery disease	6.83e-06	4.96e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	6.82e-06	4.95e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—C3—coronary artery disease	6.81e-06	4.94e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NOS3—coronary artery disease	6.77e-06	4.91e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	6.76e-06	4.9e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—C3—coronary artery disease	6.75e-06	4.9e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	6.73e-06	4.89e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GOT1—coronary artery disease	6.68e-06	4.85e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GGT1—coronary artery disease	6.68e-06	4.85e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PPARG—coronary artery disease	6.61e-06	4.79e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—JAK2—coronary artery disease	6.58e-06	4.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	6.52e-06	4.73e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—POMC—coronary artery disease	6.52e-06	4.73e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	6.5e-06	4.71e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AGT—coronary artery disease	6.49e-06	4.71e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AGT—coronary artery disease	6.47e-06	4.7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—PIK3CA—coronary artery disease	6.45e-06	4.68e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	6.43e-06	4.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AGT—coronary artery disease	6.41e-06	4.65e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOE—coronary artery disease	6.36e-06	4.62e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LEP—coronary artery disease	6.36e-06	4.62e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—VCAN—coronary artery disease	6.35e-06	4.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LEP—coronary artery disease	6.34e-06	4.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOE—coronary artery disease	6.34e-06	4.6e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALDOA—coronary artery disease	6.3e-06	4.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOA1—coronary artery disease	6.29e-06	4.56e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LEP—coronary artery disease	6.28e-06	4.56e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOE—coronary artery disease	6.28e-06	4.56e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOA1—coronary artery disease	6.27e-06	4.55e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KDR—coronary artery disease	6.23e-06	4.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KDR—coronary artery disease	6.21e-06	4.51e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOA1—coronary artery disease	6.21e-06	4.51e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	6.19e-06	4.49e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	6.17e-06	4.48e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KDR—coronary artery disease	6.15e-06	4.47e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—DCN—coronary artery disease	6.12e-06	4.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	6.11e-06	4.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ESR1—coronary artery disease	6.07e-06	4.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ESR1—coronary artery disease	6.06e-06	4.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCL8—coronary artery disease	6.01e-06	4.36e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FN1—coronary artery disease	6e-06	4.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—F2—coronary artery disease	6e-06	4.35e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTP1—coronary artery disease	6e-06	4.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ESR1—coronary artery disease	6e-06	4.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FN1—coronary artery disease	5.98e-06	4.34e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—F2—coronary artery disease	5.98e-06	4.34e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	5.98e-06	4.34e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	5.96e-06	4.32e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALDH2—coronary artery disease	5.95e-06	4.32e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	5.94e-06	4.31e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALB—coronary artery disease	5.94e-06	4.31e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	5.93e-06	4.3e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—F2—coronary artery disease	5.92e-06	4.3e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FN1—coronary artery disease	5.92e-06	4.3e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMOX1—coronary artery disease	5.92e-06	4.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	5.91e-06	4.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	5.9e-06	4.28e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	5.85e-06	4.25e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CAT—coronary artery disease	5.84e-06	4.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AKT1—coronary artery disease	5.8e-06	4.21e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LIPC—coronary artery disease	5.8e-06	4.21e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HBA1—coronary artery disease	5.8e-06	4.21e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	5.8e-06	4.21e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	5.8e-06	4.21e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOC3—coronary artery disease	5.76e-06	4.18e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CASP3—coronary artery disease	5.75e-06	4.17e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KIT—coronary artery disease	5.74e-06	4.17e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LDLR—coronary artery disease	5.73e-06	4.16e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KIT—coronary artery disease	5.72e-06	4.15e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—coronary artery disease	5.71e-06	4.14e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—NOS3—coronary artery disease	5.68e-06	4.12e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KIT—coronary artery disease	5.67e-06	4.11e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOB—coronary artery disease	5.67e-06	4.11e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	5.66e-06	4.11e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTT1—coronary artery disease	5.66e-06	4.11e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCND1—coronary artery disease	5.59e-06	4.06e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GCLC—coronary artery disease	5.59e-06	4.06e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CETP—coronary artery disease	5.59e-06	4.06e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SDC1—coronary artery disease	5.53e-06	4.01e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTM1—coronary artery disease	5.51e-06	4e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	5.51e-06	4e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	5.49e-06	3.99e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—POMC—coronary artery disease	5.47e-06	3.97e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CREB1—coronary artery disease	5.47e-06	3.97e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—POMC—coronary artery disease	5.45e-06	3.95e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CREB1—coronary artery disease	5.45e-06	3.95e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	5.44e-06	3.95e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MMP9—coronary artery disease	5.43e-06	3.94e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—LPL—coronary artery disease	5.41e-06	3.93e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—POMC—coronary artery disease	5.4e-06	3.92e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CREB1—coronary artery disease	5.4e-06	3.92e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCL2—coronary artery disease	5.35e-06	3.88e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6R—coronary artery disease	5.33e-06	3.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCL2—coronary artery disease	5.33e-06	3.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6R—coronary artery disease	5.32e-06	3.86e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCL2—coronary artery disease	5.28e-06	3.83e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPX1—coronary artery disease	5.28e-06	3.83e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AKT1—coronary artery disease	5.27e-06	3.82e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6R—coronary artery disease	5.26e-06	3.82e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF1—coronary artery disease	5.26e-06	3.82e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF1—coronary artery disease	5.24e-06	3.8e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	5.23e-06	3.8e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PSMB5—coronary artery disease	5.22e-06	3.79e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PSMA6—coronary artery disease	5.22e-06	3.79e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	5.22e-06	3.79e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS2—coronary artery disease	5.2e-06	3.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF1—coronary artery disease	5.19e-06	3.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	5.17e-06	3.75e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CD36—coronary artery disease	5.14e-06	3.73e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CTGF—coronary artery disease	5.1e-06	3.7e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPP2CA—coronary artery disease	5.08e-06	3.68e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMGCR—coronary artery disease	5.06e-06	3.67e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GOT2—coronary artery disease	5.06e-06	3.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	5e-06	3.63e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	4.99e-06	3.62e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	4.98e-06	3.62e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	4.98e-06	3.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.94e-06	3.58e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	4.93e-06	3.58e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—VEGFA—coronary artery disease	4.88e-06	3.54e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MTHFR—coronary artery disease	4.87e-06	3.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGF2—coronary artery disease	4.83e-06	3.51e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGF2—coronary artery disease	4.82e-06	3.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGF2—coronary artery disease	4.77e-06	3.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NOS3—coronary artery disease	4.77e-06	3.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NOS3—coronary artery disease	4.75e-06	3.45e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NOS3—coronary artery disease	4.71e-06	3.41e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PLCB1—coronary artery disease	4.65e-06	3.38e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—JAK2—coronary artery disease	4.63e-06	3.36e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AGT—coronary artery disease	4.63e-06	3.36e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—JAK2—coronary artery disease	4.62e-06	3.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—JAK2—coronary artery disease	4.57e-06	3.32e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	4.54e-06	3.3e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOE—coronary artery disease	4.54e-06	3.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	4.53e-06	3.28e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ABCA1—coronary artery disease	4.51e-06	3.27e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOA1—coronary artery disease	4.48e-06	3.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	4.48e-06	3.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	4.48e-06	3.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	4.39e-06	3.19e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GOT1—coronary artery disease	4.37e-06	3.17e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GGT1—coronary artery disease	4.37e-06	3.17e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	4.23e-06	3.07e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	4.22e-06	3.06e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	4.17e-06	3.03e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	4.08e-06	2.96e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	4.07e-06	2.95e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CASP3—coronary artery disease	4.05e-06	2.94e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CASP3—coronary artery disease	4.03e-06	2.93e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	4.03e-06	2.93e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—coronary artery disease	4.02e-06	2.92e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—coronary artery disease	4.01e-06	2.91e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CASP3—coronary artery disease	4e-06	2.9e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—coronary artery disease	3.97e-06	2.88e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARG—coronary artery disease	3.95e-06	2.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCND1—coronary artery disease	3.94e-06	2.86e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCND1—coronary artery disease	3.93e-06	2.85e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.92e-06	2.85e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—POMC—coronary artery disease	3.9e-06	2.83e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCND1—coronary artery disease	3.89e-06	2.82e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.89e-06	2.82e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.87e-06	2.81e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP9—coronary artery disease	3.82e-06	2.78e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CAT—coronary artery disease	3.82e-06	2.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP9—coronary artery disease	3.81e-06	2.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	3.81e-06	2.76e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP9—coronary artery disease	3.78e-06	2.74e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	3.71e-06	2.69e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOB—coronary artery disease	3.7e-06	2.69e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	3.7e-06	2.68e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	3.66e-06	2.66e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.6e-06	2.62e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALB—coronary artery disease	3.55e-06	2.58e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LPL—coronary artery disease	3.54e-06	2.57e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPX1—coronary artery disease	3.45e-06	2.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	3.43e-06	2.49e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	3.42e-06	2.48e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NOS3—coronary artery disease	3.4e-06	2.47e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	3.39e-06	2.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—coronary artery disease	3.37e-06	2.45e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CD36—coronary artery disease	3.36e-06	2.44e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.32e-06	2.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CA—coronary artery disease	3.2e-06	2.32e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MTHFR—coronary artery disease	3.19e-06	2.31e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	3.15e-06	2.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	3.14e-06	2.28e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKT1—coronary artery disease	3.11e-06	2.26e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	3.11e-06	2.26e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.11e-06	2.26e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	3.09e-06	2.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	3.08e-06	2.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	3.05e-06	2.21e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AGT—coronary artery disease	3.03e-06	2.2e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOE—coronary artery disease	2.97e-06	2.15e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOA1—coronary artery disease	2.93e-06	2.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	2.68e-06	1.95e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	2.67e-06	1.94e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	2.65e-06	1.92e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AKT1—coronary artery disease	2.61e-06	1.9e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARG—coronary artery disease	2.58e-06	1.87e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—POMC—coronary artery disease	2.55e-06	1.85e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—coronary artery disease	2.38e-06	1.72e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—coronary artery disease	2.37e-06	1.72e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—coronary artery disease	2.34e-06	1.7e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALB—coronary artery disease	2.32e-06	1.69e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NOS3—coronary artery disease	2.22e-06	1.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT1—coronary artery disease	2.19e-06	1.59e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT1—coronary artery disease	2.18e-06	1.59e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT1—coronary artery disease	2.16e-06	1.57e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.03e-06	1.47e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.91e-06	1.39e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AKT1—coronary artery disease	1.56e-06	1.13e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.25e-06	9.07e-06	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKT1—coronary artery disease	1.02e-06	7.41e-06	CbGpPWpGaD
